Editorial Board ::: Current Stem Cell Research & Therapy

ISSN: 2212-3946 (Online)
ISSN: 1574-888X (Print)


Volume 12, 8 Issues, 2017


Download PDF Flyer




Current Stem Cell Research & Therapy

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Anthony Atala
Wake Forest University School of Medicine,
Medical Center Boulevard
Winston Salem, NC 27157
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.684
5 - Year: 2.394

Editorial Board

Editor-in-Chief:

Anthony Atala (Biography
Anthony Atala

Dr. Atala is the Director of The Institute for Regenerative Medicine at Wake Forest School of Medicine. He is a practicing surgeon and a researcher in the area of regenerative medicine, growing new human cells, tissues and organs. In 2011 he was elected to the National Academy of Medicine. He was featured in U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century. Over 10 applications of technologies developed in his laboratory have been used clinically. He is editor of 20 books, has published over 500 journal articles, and has applied for or received over 200 patents.

)

Wake Forest University School of Medicine,
Medical Center Boulevard
Winston Salem, NC 27157
USA



Associate Editor:

Xiaosong Gu (Biography
Xiaosong Gu

Professor Xiaosong Gu is the director of China National Ministry of Education and Jiangsu Key Lab of Neuroregeneration and is a member of the Chinese Academy of Engineering. He has led an active research team to make outstanding innovative achievements in the fields of tissue engineering and nerve regeneration. In brief, (1) tissue engineered nerve and nerve regeneration; (2) translation of tissue engineered nerve grafts to the clinic; (3) the regulatory roles and mechanisms of non-coding RNAs in peripheral nerve regeneration. Pro. Gu has published more than 100 academic articles in SCI-indexed journals, which includes Nature Communication, Brain, Progress in Neurobiology, Biomaterials, NAR and so on. And he also holds a number of Chinese and international invention patents.

)

Nantong University
Nantong
China


Regional Editors:

G. Almeida-Porada (Biography
G. Almeida-Porada

Dr. Graça Almeida-Porada, is a Professor of Regenerative Medicine at Wake Forest Institute for Regenerative Medicine, and School of Biomedical Engineering and Sciences. Dr. Almeida-Porada holds a M.D., and Ph.D. in Pathology from ICBAS, University of Porto, and trained in Hematology/Transfusion Medicine at Centro Hospitalar do Porto. Her research focuses on the development of cellular and gene delivery platforms to treat genetic and immune-mediated diseases. She is particularly interested in improving the outcome of stem cell and gene therapy in fetal and neonatal patients with genetic diseases, and developing immunomodulatory therapies for patients with immune-mediated disorders. She is the Co-founder of the International Fetal Transplantation and Immunology Society. Dr. Almeida-Porada holds several patents and has authored more than 200 scientific works including papers, abstracts, and book chapters.

)

Wake Forest University School of Medicine
Winston Salem
NC
USA

Pritinder Kaur
Peter MacCallum Cancer Centre
Melbourne
Australia

Dimas Covas
Faculdade de Medicina de Ribeirão Preto
Ribeirão Preto
SP
Brazil

Il-Hoan Oh (Biography
Il-Hoan Oh

Dr. Oh is director for Center for Next Generation for Stem Cell Based Cell Therapeutics, nominated by Korean FDA and director for Catholic High Performance Cell Therapy Center, in Catholic University of Korea, College of Medicine, Seoul. He served as President of Korean Society of Stem Cell Research (KSSCR) and currently serving as CEO in the board meeting of KSSCR. He also serves as advisory member for Presidential Committee for National Bioethics, Korea. He graduated Catholic Medical School, Seoul, Korea, earned Ph.D in Temple University, USA, worked as National Research Fellow for Canadian Society for Cancer Research. His main focus of research is the regulation of hematopoietic stem cells and mesenchymal stromal cells in the light of tissue regeneration. He also serves as an International Committee Member for International Society for Stem Cell Research (ISSCR).

)

The Catholic University of Korea
Seoul
South Korea

Joseph Itskovitz-Eldor
Rambam Medical Center
Haifa
Israel

Rocha Vanderson
University of Oxford
Oxford
OX1 2JD
UK


Editorial Board Members:

I. Ahmad
Durham Research Center
Omaha, NE
USA

M. Alison
Queen Mary University of London
London
UK

N. Askenasy
Schneider Children's Medical Center of Israel
Petach Tikva
Israel

M. Azzouz
The University of Sheffield
Sheffield
UK

K. Ballen (Biography
K. Ballen

Dr. Karen Ballen is Professor of Medicine at Harvard Medical School in Boston, United States and the Director of the Leukemia Program at Massachusetts General Hospital. She was graduated from Harvard College and Dartmouth Medical School. Her career has been devoted to the care of patients with leukemia and patients needing stem cell transplantation. Her clinical research expertise is in umbilical cord blood transplantation and outcome results. She has published over 150 papers on this topic. She is the Chairman of the Cord Blood Advisory Committee of the National Marrow Donor Program, and serves on the Advisory Board of the Center for International Blood and Marrow Transplant Research. She is Associate Editor of the journal Bone Marrow Transplantation.

)

Massachusetts General Hospital
Boston, MA
USA

G. Barosi
Laboratorio di Epidemiologia Clinica
Pavia
Italy

E. Bieberich
Georgia Regents University
Augusta, GA
USA

R.M. Bohmer
Genetic Technologies Pty Ltd.
Melbourne
Australia

D.A. Breems
Erasmus University Medical Centre
Rotterdam
The Netherlands

M. Brittan
Cancer Research UK
London
UK

R. Burt
Northwestern University School of Medicine
Chicago, IL
USA

K.A. de Carvalho (Biography
K.A. de Carvalho

Medical Doctor, Neurologist and Paediatrician title obtained in University of São Paulo, Brazil; Specialisation in biology, pathology and neuromuscular development, Université Paris VII and Pitié Salpêtrière Hospital, France, PhD (1988 to 1990); Master of Science (MsC) in Neurology, USP (1994) and second PhD in Bioprocess and biotechnology in Health Science, Federal University of Paraná, Brazil (2006). From 2001 to 2008, head of the Experimental Preclinical Laboratory Research on stem cell therapy and translation at the Pontifical Catholic University of Paraná. Since 2006, head of the “Cell Therapy and Biotechnology in Regenerative Medicine” Research Group, particularly in Neurodegenerative Diseases at the Pelé Pequeno Príncipe Institute, Curitiba, Paraná, Brazil. Researcher from Bench-to-bedside. Professor of Pequeno Príncipe College, Supervisor of Bachelor, Master and Doctoral Theses. Editor and patent’s author.

)

Paraná Federal University
Paraná
Brazil

J.C. Chachques
European Hospital Georges Pompidou
Paris
France

J. Chen
NHLBI
Bethesda, MD
USA

R. Clarke
University of Manchester
Manchester
UK

M.H. Dahlke (Biography
M.H. Dahlke

Professor Marc H. Dahlke is a lecturer for experimental surgery at Regensburg University, Germany. He is also an attending surgeon at Regensburg University Medical Center. Dr Dahlke has received his MD degree from Hannover Medical School in 2002 and his PhD degree from the same institution in 2004 after graduating from the MD/PhD program for molecular medicine. He has received specialty training in surgery as a fellow at the University of Sydney (Australia) and at Memorial Sloan Kettering Cancer Center in New York, USA.

)

University of Regensburg
Regensburg
Germany

B. Datta (Biography
B. Datta

Dr. Datta is as Associate Professor at the Department of Chemistry & Biochemistry, Kent State University. He obtained his doctorate (Ph.D.) in Chemistry from University of Nebraska at Lincoln and Post-doctoral experience from Yale University School of Medicine. Dr. Datta works on tumor suppressor protein, p67 and has published more than 50 research articles. Dr. Datta teaches two semester Biochemistry courses for senior undergraduate and graduate students.

)

Kent State University
Kent, OH
USA

G. Dontu
University of Michigan
Michigan, MI
USA

C. Dufour
G. Gaslini Children's Hospital
Genova
Italy

S. Farag
The Ohio State University
Columbus, OH
USA

G.G. Jinesh
UT MD Anderson Cancer Center
Houston, TX
United States

P.P. Lehenkari
University of Oulu
Oulu
Finland

F. Locatelli
IRCCS Policlinico San Matteo
Pavia
Italy

M.P. Lutolf
Stanford University School of Medicine
Stanford, CA
USA

O.M. Martinez-Estrada
Western General Hospital
Edinburgh, EH
UK

M.H. Maurer
University of Heidelberg
Heidelberg
Germany

A.R. Migliaccio (Biography
A.R. Migliaccio

Dr. Migliaccio is Professor of Medicine, at the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai New York, NY, USA and Professor for “Chiara Farma” in the Faculty of Medicine, University Alma Mater, Bologna, Italy. She received her PhD in Natural Science in 1975 and in Biological Science in 1977 both with 110/110 cum laude from the University of Naples, Naples, Italy. She has published more than 180 papers in peer reviewed journals and 15 book chapters on subjects related to experimental hematology as well as on normal and pathological erythropoiesis and is member of the editorial boards for all the major hematological journals.

)

Istituto Superiore Sanita
Rome
Italy

M. Modo (Biography
M. Modo

Dr. Modo is an Associate Professor in the Department of Radiology and Bioengineering at the University of Pittsburgh, USA. Prior to joining the University of Pittsburgh in 2011, he was a Senior Lecturer at the Institute of Psychiatry, King’s College London, where he also obtained his PhD in neuroscience. His main interest lies in repairing the stroke-damaged brain, foremost by employing neural stem cells, but also more recently using biomaterials. To visualize the repair process, Dr Modo employs non-invasive imaging, such as magnetic resonance imaging. In 2013, Dr Modo received the Bernard Sanberg Memorial Award for Brain Repair by the American Society for Neural Transplantation and Repair.

)

Institute of Psychiatry
London
UK

T. Mori (Biography
T. Mori

Dr. Takehiko Mori is an Associate Professor of Division of Hematology at Keio University School of Medicine in Tokyo, Japan.

Dr. Mori graduated from Keio University School of Medicine in Tokyo, Japan, in 1993. He completed a Postgraduate course of Internal Medicine (Hematology) at Keio University School of Medicine in 1997. Prior to his current roles, he was an Assistant Professor of Division of Hematology at Keio University School of Medicine.

Dr Mori’s specialties are hematological disorders and malignancies, hematopoietic stem cell transplantation, opportunistic infection and hospital infection control.

)

Keio University School of Medicine
Tokyo
Japan

M.O. Muench (Biography
M.O. Muench

Dr. Muench received his doctorate (Ph.D.) in Cell Biology & Genetics from the Joan and Sanford I. Weill Medical College of Cornell University. He also obtained a B.S. degree in Genetics from the University of California at Davis and an A.S. degree in Physical Sciences from the College of Marin. Currently, Dr. Muench is a Senior Scientist at Blood Systems Research Institute in San Francisco and an Adjunct Associate Professor in the Department of Laboratory Medicine at the University of California San Francisco. Dr. Muench has published over 100 peer-reviewed papers, review articles and book chapters.

)

University of California San Francisco
San Francisco, CA
USA

H Murakami (Biography
H Murakami

Dr. Murakami obtained a doctorate (PhD) in 1978 at Gunma University, Gunma, Japan, and is now the Dean of Gunma University Graduate School of Health Sciences, and engaged in the education of the health care workers. He has about 35 years of experience in research and clinical medicine in hematological disorders, especially in multiple myeloma, and has published more than 100 scientific articles.

He acts as the President of Japan Myeloma Society and the board member of International Myeloma Society.

)

Gunma University
Gunma
Japan

R. Nagler
Rambam Medical Center and Technion Medical School
Haifa
Israel

D.S. Nascimnto (Biography
D.S. Nascimnto

DS Nascimento got her PhD in Zoology by the University of Aberdeen, UK, in 2008. In the same year she became a PostDoc fellow at INEB, where she is an Assistant Investigator from 2015. She has accumulated extensive expertise in the study of the heart in physiological and pathological conditions. Development of efficient therapies to treat heart failure is her long-term goal. She has been appointed member staff of the Bioimaging Centre for Biomaterials and Regenerative Therapies of INEB and she is an Invited Assistant Professor at Instituto de Ciências Biomédicas Abel Salazar (ICBAS) of the University of Porto.

)

Universidade do Porto
Porto
Portugal

K. Nishida
Osaka University Medical School
Suita
Japan

S. Nomura
Kansai Medical University
Osaka
Japan

K. O'Donoghue
Queen Charlotte's and Chelsea Hospital and Imperial College London
London
UK

O. Parolini
Fondazione Poliambulanza – Istituto Ospedaliero
Brescia
Italy

C. Wang
Cedars-Sinai Medical Center
Los Angeles, CA
USA

F. West
University of Tennessee Cancer Institute
Southhaven, MS
USA

D.P. Wolf
Oregon National Primate Research Center
Beaverton, OR
USA

M. Wu
University of North Dakota
Grand Forks, ND
USA

T. Xie
Stowers Institute for Medical Research
Kansas, MO
USA

K. Yates
Brigham and Women's Hospital
Boston, MA
USA

J. Yu (Biography
J. Yu

John S. Yu is the Medical Director of the Brain Tumor Center at Cedars-Sinai Medical Center. He is Professor and Vice Chair in the Department of Neurosurgery. He is conducting research in immune and stem cell therapy for brain tumors. He is the founder and director of Immunocellular Therapeutics, a clinical stage public biotech company located in Calabasas, California. He earned his bachelor's degree from Stanford University and spent a year at the Sorbonne in Paris studying French literature. He completed his fellowship in immunology at the Institut Pasteur in Paris. He earned his medical degree from Harvard Medical School and master's degree from the Harvard University Department of Genetics.

)

Cedars-Sinai Medical Center
Los Angeles, CA
USA

X. Zeng
National Institute on Drug Abuse, NIH
Baltimore, MD
USA

G. de Cerqueira Daltro
Universidade Federal da Bahia
Salvador
Brazil

R. Akkina
Colorado State University
Fort Collins, CO
USA

I. André-Schmutz
Hopital Necker-Enfants Malades
Paris
France

W.Y. Au
University of Hong Kong
Hong Kong
China

P Bader (Biography
P Bader

Peter Bader, MD is Professor of Paediatrics at the Johann Wolfgang Goethe University in Frankfurt a. M., Germany. He received his medical degree from the Eberhard-Karls-University in Tübingen. Since October 2004 he is Head of the Division for Stem Cell Transplantation and Immunology and Vice Director of the University Children’s Hospital in Frankfurt a. M., Germany.

Prof. Bader has authored more than 200 manuscripts. Since 2014 Prof. Bader is chairman of the Pediatric Diseases Working Party (PDWP) of the European Group for Blood and Marrow Transplantation (EBMT). His research is focused in particular on pre emptive strategies to prevent relapse after allogeneic stem cell transplantation in children and adolescence with malignant diseases.

)

University Children's Hospital
Frankfurt
Germany

G. Banna (Biography
G. Banna

Dr. Banna, MD since 1998 and Oncologist since 2002, is currently working in Catania, Italy, as Clinical Lead of a Division of Medical Oncology and take a particular clinical and research interest in thoracic and genitourinary cancers, anticancer oral therapy, gynecological hereditary tumors and cancer stem cell. He promoted local multidisciplinary clinical activities and research in these fields. He contributed to the publication of several papers in scientific journal, as well as presentations at and organization of local and national conference. He spent observerships at the Lung Cancer Unit of the Guy’s Hospital and at the MD Anderson Cancer Center.

)

Humanitas Clinical Institute
Milan
Italy

M. Bhatia
McMaster University
Ontario
Canada

M.R. Bishop
National Cancer Institute
Bethesda, MD
USA

J.A. Boockvar
Weill Cornell Medical College
New York, NY
USA

S. Brenner
University Clinic Carl Gustav Carus
Dresden
Germany

T.H. Brümmendorf
University-Klinikum Hamburg-Eppendorf
Hamburg
Germany

M.R. Canninga-van Dijk
University Med. Ctr. Utrecht
Utrecht
The Netherlands

M. Cavo
University of Bologna
Bologna
Italy

S. Chakrabarti (Biography
S. Chakrabarti

Suparno Chakrabarti is the Program Director for Blood and Marrow Transplantation at Dharamshila Hospital and Research Centre, New Delhi, India. He initiated the first Haploidentical BMT program in India and along with Dr Sarita Jaiswal has developed this as a sustained alternate donor program with over 50 Haploidentical transplants in the past 4 years. They have explored modifications of PTCY based protocols with PBSC graft to improve the outcome of Haploidentical transplantation in Refractory leukemia, Aplastic Anemia and Hemoglobinopathies.Dr Chakrabarti trained in Internal Medicine at PGIMER,Chandigarh in India. Subsequently, he spent 12 years in the UK, initially as a research fellow and subsequently as a consultant. During this period, he played a substantial role in developing Campath-1H based T cell depletion and reduced intensity conditioning. The bulk of his research also focussed on post-transplant virus infections. He has over 80 publications to his credit.

)

Bristol Royal Hospital for Sick Children
Bristol
UK

Y.-B. Chen
Massachusetts General Hospital Cancer Center
Needham, MA
USA

M. Conese (Biography
M. Conese

Prof. Massimo Conese received his Ph.D. in Cellular and Molecular Biology and Pathology from the University of Naples, Italy. During the Ph.D., he spent one year and a half at the Institute of Microbiology, University of Copenhagen, Denmark. Currently, Prof. Conese is Associate Professor in Pathology at the University of Foggia, Italy. Previously, he was Research Assistant at the Telethon Institute for Gene Therapy and Group Leader of the Institute for Experimental Treatment of Cystic Fibrosis, H. S. Raffaele, Milan, Italy. He has published more than 100 scientific publications and is co-authors in 10 chapter books.

)

University of Foggia
Foggia
Italy

M. Dalby
University of Glasgow
Glasgow
UK

R. Day
King's College London
London
UK

L. Drayer
Sanquin Blood Bank North East
Groningen
The Netherlands

L.M. Eisenberg
New York Medical College
Valhalla, NY
USA

J. Guicheux (Biography
J. Guicheux

Jerome Guicheux, PhD-D.Sc., INSERM research director/professor JG is the co-director of the INSERM lab U791 (Nantes, France). JG is the elected president of the French Society for mineralized tissue biology and the national coordinator of the french osteoarthritis network. He is author or coauthor of 140 international publications (h-index 42), 8 patents and 71 invited lectures. His research activities focus on the development, pathophysiology and regenerative medicine of the skeleton with particular attention to stem cells and biomaterials for the repair of cartilage and intervertebral disc.

)

Nantes University
Nantes
France

H. Jørgensen
University of Glasgow
Glasgow
UK

S.C. Li (Biography
S.C. Li

Dr. Li obtained his PhD at Mount Sinai School of Medicine, postdoctoral at Whitehead Institute of Massachusetts Institute of Technology, fellowship at Harvard Medical School. He is Principal Investigator at CHOC Children’s Hospital/University of California-Irvine School of Medicine and adjunct professor of California State University Fullerton and Sun Yat-sen University. He has 148+ publications including the peer-reviewed articles and 25 U.S.-issued patents, as remarked in Nature, Science, Cell, Annual Reviews of Cell and Developmental Biology, with citations of 7,000+. He serves on editorial board of American Journal of Pathology (2008-) and as member of ACTS, ISSCR, SfN, ASCB, ASN, ASIP.

)

University of California Irvine
Orange, CA
United States

L.H.J. Looijenga (Biography
L.H.J. Looijenga

Dr. Looijenga is Professor of Translational Patholo-Oncology at the Erasmus Medical Center (Rotterdam, The Netherlands), leading a research group within the Department of Pathology. His research is focused on development and application of diagnostic, prognostic and predictive markers (including esophageal-, head and neck- and germ cell cancers as well as (in)fertility). The latter topic relates to regulation of Disorders of Sex Development (DSD), pluripotency and cisplatin sensitivity and resistance, sex determination (gonadal development), germ cell maturation and transformation. He studied biology at the University of Groningen and graduated cum laude with a specialization in medical cell biology in 1989. He has been invited for more than 200 key note lectures, had over 40 funded research grants, and has more than 225 publications (39 first, 131 co- and 107 last authorships), as well as over 25 book chapters.

)

Erasmus University Medical Center
Rotterdam
The Netherlands

M. Magagnoli
Istituto Clinico Humanitas
Milano
Italy

M. Martino
Azienda Ospedaliera Bianchi-Melacrino-Morelli
Calabria
Italy

C.P. McGuckin
University of Newcastle
Newcastle
UK

N. Minato
Kyoto University
Kyoto
Japan

M Mohty
Institut Paoli-Calmettes
Marseille
France

R.J Morris
Columbia University College of Phys. and Surg.
New York, NY
USA

C. Mullighan
St. Jude Children's Research Hospital
Memphis, TN
USA

H. Mutoh
Jichi Medical School
Yakushiji
Japan

T Nakano
Osaka University
Osaka
Japan

R. Nat
Karolinska Institutet
Huddinge
Sweden

M. Noble
University of Rechester Medical Center
Rechester, NY
USA

N. Novitzky
University of Cape Town
Cape Town
South Africa

H.C. O'Neill (Biography
H.C. O'Neill

Professor Helen C. O’Neill is currently Director of the Clem Jones Research Centre for Regenerative Medicine at Bond University on the Gold Coast in Australia, where she holds a Chair in Immunology and Stem Cell Biology. Previously Professor O’Neill was Head of the Stem Cell and Immunology Laboratory at the Australian National University where she held an academic position for over 30 years. Early in her career she was twice a Visiting Fellow in the Weissman Laboratory at Stanford University. The overall theme of her work is the development of strategies for stem cell-based immunotherapy and regenerative medicine.

)

The Australian National University
Canberra
Australia

B.P. Samper (Biography
B.P. Samper

Dr. Pelacho is Researcher at the Center for Applied Medicine Research (CIMA) and Assistant Professor at the University of Navarra (Spain). She has more than 10 years of experience in research and development of novel therapies aimed to treat cardiovascular diseases. Previously, Dr. Pelacho performed a post-doctoral stay at the University of Minnesota (Stem Cell Institute), developing studies focussed in the application of stem cell therapy for the treatment of myocardial infarction. During her career at the University of Navarra, she obtained a Ph.D. in Biochemistry. Dr. Pelacho has authored more than 40 manuscripts and has obtained several national and international grants as principal investigator.

)

Center for Applied Medical Research
Pamplona
Spain

F.M. Watt
Cancer Research UK London Research Institute
London
UK

M Westphal
University Hospital Hamburg Eppendorf,
Hamburg
Germany

J.M. Wolosin
Mount Sinai School of Medicine
New York, NY
USA

N.M. Wulffraat
University Medical Center Utrecht
Utrecht
The Netherlands

C Xu (Biography
C Xu

Chunhui Xu, Ph.D., is an Associate Professor in the Department of Pediatrics, Emory University School of Medicine. Dr. Xu has extensive research experience on stem cells and cardiogenesis. Her research is focusing on cardiomyocytes derived from human pluripotent stem cells (hPSCs), which hold promise for cardiac cell therapy, disease modeling, drug discovery, and the study of developmental biology. Her group has made significant contribution to the field of pluripotent stem cells. Several of their publications have been identified as a hot paper or among the most highly cited publications in the field of hPSCs. She is an inventor or co-inventor of 16 issued US patents, and her work has been cited more than 7,000 times according to Google Scholar.

)

Emory University School of Medicine
Atlanta, GA
USA

Y.-S. Yoon
Emory University
Atlanta, GA
USA

R.K Yu
Medical College of Georgia
Augusta, GA
USA

C.M. Zwaan
Erasmus MC/Sophia Children's Hospital
Rotterdam
The Netherlands

A. de Grey (Biography
A. de Grey

Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA, and is the Chief Science Officer of SENS Research Foundation, a California-based 501(c)(3) biomedical research charity that performs and funds laboratory research dedicated to combating the aging process. He received his Ph.D. in biology from the University of Cambridge. His research interests encompass the characterisation of all the accumulating and eventually pathogenic molecular and cellular side-effects of metabolism (“damage”) that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.

)

SENS Research Foundation
Mountain View
USA

F. Alderuccio
Monash University
Victoria
Australia

P. Anversa
Cardiovascular Research Institute
New York, NY
USA

F. Aversa
University of Perugia
Perugia
Italy

H. Baharvand (Biography
H. Baharvand

Hossein Baharvand is a distinguished Professor and Director of Royan Institute for Stem Cell Biology and Technology. He has focused his research interests on improving the translational research and regenerative medicine mainly through the understanding of Stem Cells and Developmental Biology and Biologically inspired Engineering. He is the editor of four international books. He has published 265 international peer-reviewed papers, as well as seven chapters in international books. As of Sep 2016, Google Scholar reports over 5600 citations and h-index 40 to his work. He has received 29 international and national awards including the United Nations Educational, Scientific and Cultural Organization (UNESCO)-Equatorial Guinea international prize (2014) for research in life sciences aimed at improving the quality of human life with his stem cell research and its numerous applications in regenerative medicine.

)

Royan Institute
Tehran
Iran

M.H. Baron
Icahn School of Medicine
New York, NY
USA

K. Bieback
Inst. of Transfusion Medicine and Immunology
Mannheim
Germany

O. Bock
Hannover Medical School
Hannover
Germany

D. Bosnakovski
University “Goce Delcev” Stip
Stip
Republic of Macedonia

M.K. Brenner
Center for Cell and Gene Therapy
Houston, TX
USA

C. Burns
NIBSC
Potters Bar Herts
UK

C. Carlo-Stella
Istituto Nazionale Tumori
Milano
Italy

S. Cesaro
University of Padova
Padova
Italy

N.J. Chao (Biography
N.J. Chao

Nelson J. Chao is the Donald D. and Elizabeth G. Cooke Professor in Cancer Research and Professor of Medicine and Immunology and the Chief of the Division of Hematological Malignancies and the Division of Cellular Therapy/BMT at Duke University. He received his undergraduate degree from Harvard University, MD from Yale University and his post-graduate training at Stanford University. He was the Associate Director of Stem Cell Transplantation at Stanford University prior to moving to Duke University in 1996 as the Director of the Bone Marrow Transplantation Program. He is also the Director of Global Cancer for the Duke Cancer Institute and the Duke Global Health Institute.

)

Duke University
Durham, NC
USA

S. Chi
Dana-Farber Cancer Institute
Boston, MA
USA

D.T. Covas
University of São Paulo
Ribeirão Preto
Brazil

M. Dao
Immatics
Houston, TX
USA

M.M Dikov
Vanderbilt University
Nashville, TN
USA

N.W.M. Drummond
University of Glasgow
Glasgow
UK

P.S. Eriksson
Goteborg University
Goteborg
Sweden

D.T. Harris (Biography
D.T. Harris

Dr. Harris is a graduate of Wake Forest University where he obtained BS in Biology, Mathematics and Psychology. He earned his Doctorate in Microbiology and Immunology in 1982. In 1989 Dr. Harris joined the faculty at the University of Arizona in the Department of Immunology. Dr. Harris established the first cord blood bank in 1992. He currently serves as the Executive Director of the University of Arizona Biorepository, as well as Director of Quality at the GMP Laboratory. His research interests include stem cells and regenerative medicine.

)

Department of Immunobiology
University of Arizona
Tucson, AZ
United States

Z. Kokaia (Biography
Z. Kokaia

Dr. Zaal Kokaia obtained a doctorate (Ph.D.) in neuroscience from the University of Lund, Sweden. Dr. Kokaia also holds PhD in neurophysiology from I. Beritashvili Institute of Physiology, Tbilisi, Georgia. Currently Dr. Kokaia is the Professor of Experimental Medial Research at Lund University, Sweden. He is also Director of Lund Stem Cell Center and heads Laboratory of Stem Cells and Restorative Neurology. He coordinates Strategic Research Area in Stem Cells and Regenerative Medicine (StemTherapy) at Lund University supported by Swedish Government. His research interests are generation and characterization of neural stem cell lines from different sources and through reprogramming and development of stem cell-based treatments for stroke.

)

Lund University
Lund
Sweden

B. Lim
Harvard Medical School
Singapore
Singapore

J.M. Luque
Universidad Miguel Hernández-CSIC
Alicante
Spain

J. Marin-Garcia
UMDNJ-Robert Wood Johnson Med. Sch.
Highland Park, NJ
USA

M. Martins-Green
University of California
Riverside, CA
USA

E. Meijer
University Medical Center Utrecht
Utrecht
The Netherlands

H. Miyake
Hyogo Medical Center for Adults
Akashi
Japan

R. Moog
University Clinics Essen
Essen
Germany

C.M. Morshead (Biography
C.M. Morshead

Dr. Morshead obtained her doctorate in Neurobiology from the University of Toronto, Toronto, Canada. She is a tenured Professor and Chair of the Division of Anatomy, Department of Surgery, at the University of Toronto. Her lab takes an interdisciplinary approach to develop novel therapeutics for neural regeneration that are informed by studies of the fundamental biology of neural stem cells.

)

University of Toronto
Toronto
Canada

C. Mummery
Netherlands Inst. for Develop. Biol.
Utrecht
The Netherlands

M. Nagano
McGill University
Montreal
Canada

K. Nakashima (Biography
K. Nakashima

Kinichi Nakashima, Ph.D. is a Professor in Department of Stem Cell Biology and Medicine, Graduate School of Medical Sciences, Kyushu University, Japan. He received his Ph.D. in Chemistry from the Kyushu University in 1995. He did postdoc at Osaka University and Tokyo Medical and Dental University (1995-1997) and became an assistant professor at Tokyo Medical and Dental University in 1998. He then became an associate professor at Kumamoto University in 2000. He moved to the Salk Institute as a research fellow (2002-2004), and become a professor at Nara Institute of Science and Technology (NAIST) and obtained the present position in 2013. Dr. Nakashima ’s research focuses on neural stem cell (NSC) regulation by epigenetic programs.

)

Kyushu University
Fukuoka
Japan

P. Niemeyer
Freiburg University Hospital
Freiburg
Germany

G. Noia
Catholic University of the Sacred Heart
Rome
Italy

D. Noël (Biography
D. Noël

Danièle Noël is currently research director in the Inserm Institute for Regenerative Medicine and Biotherapies in Montpellier. She received her Ph.D. in Health Biology from the Bordeaux University in 1992. She did a post-doc in the Institute of Molecular Genetics in Montpellier in the field of recombinant retrovirology and gene therapy (1992-1999). She then moved to the Inserm u475 in Montpellier to work in cell therapy and obtained a permanent position in 2007. She became professor in 2011. Her main interests are mesenchymal stem cells and their applications in the treatment of osteo-articular diseases.

)

INSERM
Montpellier
France

R. Ogawa (Biography
R. Ogawa

Professor, Rei Ogawa has the M.D. and Ph.D. degrees. He is currently a faculty member at the Nippon Medical School in Tokyo. He is a fellow of American College of Surgeons. He is now directing the Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School, Tokyo, Japan. He is also directing Mechanobiology and Mechanotherapy Laboratory at his medical school. He joined the Tissue Engineering and Wound Healing Laboratory, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA, where he worked between 2007 and 2009 as a Research Fellow. He has focused his recent studies on the mechanobiology and its application to tissue engineering, wound healing and anti-aging medicine.

)

Nippon Medical School
Tokyo
Japan

S Slavin
The International Center for Cell Therapy &Cancer Immunotherapy (CTCI)
Tel Aviv
Israel

C. Weidt
University Clinic Muenster
Muenster
Germany

W. Wiktor-Jedizejczak
The Medical University of Warsaw
Warszawa
Poland

M Wong
Oregon Health and Science University
Portland, OR
USA

C.J. Xian (Biography
C.J. Xian

Dr Xian is a Research Professor and NHMRC Senior Research Fellow at University of South Australia. He has more than 25 years of experience in research on tissue growth and repair, growth plate biology and bone growth, bone repair and regeneration, cancer chemotherapy-induced bone defects, and osteoporosis. Dr Xian obtained his PhD in 1993 from Murdoch University; and his earlier research positions include those at Child Health Research Institute, University of Adelaide, Flinders University, and Women’s and Children’s Hospital. Dr Xian has over 140 peer-reviewed publications.

)

University of South Australia
Adelaide
Australia

T. Yamane
Osaka City University
Osaka
Japan

N.T Young
University of Cambridge
Cambridge
UK

R. Zeiser
Albert Ludwigs University Freiburg
Freiburg
Germany

J. de Boer
University of Twente
Bilthoven
The Netherlands

G. de Haan
University of Groningen
Groningen
The Netherlands


Advertisement

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science